Compare ADMA Biologics Inc (ADMA) vs Upstart Holdings Inc (UPST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Upstart Holdings Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Upstart Holdings Inc trades at $29.96 (market cap $2.91B). The key difference: Upstart Holdings Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| ADMA | UPST | |
|---|---|---|
Market Cap | $2.22B | $2.91B |
Sector | Health | Financials |
52-Week High | $20.38 | $73.76 |
52-Week Low | $7.60 | $24.22 |
Enterprise Value | $2.29B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Upstart Holdings Inc
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →
